Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10851)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2014 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yau TO, Tang CM, Yu J. Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments. World J Gastroenterol 2014; 20(21): 6448-6456 [PMID: 24914366 DOI: 10.3748/wjg.v20.i21.6448] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i21/6448.htm |
| Number | Citing Articles |
| 1 |
Praphatson Malat, Tipaya Ekalaksananan, Chukkris Heawchaiyaphum, Supawadee Suebsasana, Sittiruk Roytrakul, Yodying Yingchutrakul, Chamsai Pientong. Andrographolide Inhibits Epstein–Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins. Molecules 2022; 27(14): 4666 doi: 10.3390/molecules27144666
|
| 2 |
Alejandra Alarcón, Ursula Figueroa, Bastian Espinoza, Alejandra Sandoval, Gonzalo Carrasco-Aviño, Francisco R. Aguayo, Alejandro H. Corvalan. Gastric Cancer. 2017; doi: 10.5772/intechopen.70201
|
| 3 |
Mikhail Y. Salnikov, Katelyn M. MacNeil, Joe S. Mymryk. The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1358511
|
| 4 |
Sun-mi Yun, Yeong Seok Kim, Dae Young Hur. LMP1 and 2A Induce the Expression of Nrf2 Through Akt Signaling Pathway in Epstein-Barr Virus–Transformed B Cells. Translational Oncology 2019; 12(5): 775 doi: 10.1016/j.tranon.2019.02.009
|
| 5 |
AYA SHINOZAKI-USHIKU, AKIKO KUNITA, MASASHI FUKAYAMA. Update on Epstein-Barr virus and gastric cancer (Review). International Journal of Oncology 2015; 46(4): 1421 doi: 10.3892/ijo.2015.2856
|
| 6 |
Áurea Lima, Hugo Sousa, Rui Medeiros, Amanda Nobre, Manuela Machado. PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis. Discover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00479-0
|
| 7 |
Wen Liu, Bing Luo. The Impact of EBV On the Epigenetics of Gastric Carcinoma. Future Virology 2020; 15(3): 183 doi: 10.2217/fvl-2019-0148
|
| 8 |
Wei Gong, Lei Zhang, Hui Yu, Qiang Yu, Wei‑Kang Pan, Yin Wang, Xuan‑Lin Wu, Qiang Liu. Dihydroartemisinin suppresses the proliferation of Epstein‑Barr virus‑associated gastric carcinoma cells via downregulation of latent membrane protein 2A. Oncology Letters 2018; doi: 10.3892/ol.2018.8950
|
| 9 |
Songhua Liu, Yao Rong, Mingzheng Tang, Qiqi Zhao, Chunyan Li, Wenbin Gao, Xiaojun Yang. The Functions and Mechanisms of Long Non-coding RNA SNHGs in Gastric Cancer. Combinatorial Chemistry & High Throughput Screening 2024; 27(18): 2639 doi: 10.2174/0113862073268591230928100922
|
| 10 |
Aldo Giudice, Giovanni D’Arena, Anna Crispo, Mario Felice Tecce, Flavia Nocerino, Maria Grimaldi, Emanuela Rotondo, Anna Maria D’Ursi, Mario Scrima, Massimiliano Galdiero, Gennaro Ciliberto, Mario Capunzo, Gianluigi Franci, Antonio Barbieri, Sabrina Bimonte, Maurizio Montella, Denis Delic. Role of Viral miRNAs and Epigenetic Modifications in Epstein‐Barr Virus‐Associated Gastric Carcinogenesis. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/6021934
|
| 11 |
MiaoZhen QIU, RuiHua XU. Epidemiology, molecular characteristics, and clinical application of immunotherapy strategies for EBV-associated gastric cancer. SCIENTIA SINICA Vitae 2024; 54(12): 2357 doi: 10.1360/SSV-2024-0190
|
| 12 |
Jing Zhang, Siwei Zhang, Lielian Zuo, Wenxing Yue, Shen Li, Shuyu Xin, Lingzhi Liu, Jianhong Lu. Differential expression profiling of lncRNAs related to Epstein‐Barr virus infection in the epithelial cells. Journal of Medical Virology 2019; 91(10): 1845 doi: 10.1002/jmv.25516
|
| 13 |
Iva Polakovicova, Sofia Jerez, Ignacio A. Wichmann, Alejandra Sandoval-Bórquez, Nicolás Carrasco-Véliz, Alejandro H. Corvalán. Role of microRNAs and Exosomes in Helicobacter pylori and Epstein-Barr Virus Associated Gastric Cancers. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00636
|
| 14 |
Tao Huang, Yan Ji, Dan Hu, Baozheng Chen, Hejun Zhang, Chao Li, Gang Chen, Xingguang Luo, Xiong-wei Zheng, Xiandong Lin. SNHG8 is identified as a key regulator of epstein-barr virus(EBV)-associated gastric cancer by an integrative analysis of lncRNA and mRNA expression. Oncotarget 2016; 7(49): 80990 doi: 10.18632/oncotarget.13167
|
| 15 |
Kin Israel Notarte, Suranga Senanayake, Imee Macaranas, Pia Marie Albano, Lucia Mundo, Eanna Fennell, Lorenzo Leoncini, Paul Murray. MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers. Cancers 2021; 13(15): 3909 doi: 10.3390/cancers13153909
|
| 16 |
Sarah Watson, Joanna Cyrta, Marine Lefevre, Julien Masliah Planchon, Christophe Louvet, Vincent Servois, Pauline Vaflard, François Clément Bidard, Ivan Bieche, Emilie Soularue. Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus–Associated Gastric Adenocarcinoma With ERBB2 Amplification. JCO Precision Oncology 2021; (5): 370 doi: 10.1200/PO.20.00272
|
| 17 |
Gadde Shareena, Dileep Kumar. Epigenetics of Epstein Barr virus — A review. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(8): 166838 doi: 10.1016/j.bbadis.2023.166838
|
| 18 |
Fatemeh Abbaszadeh, Sajad Fakhri, Sana Piri, Haroon Khan. Phytonutrients in the Treatment of Gastrointestinal Cancer. 2023; : 1 doi: 10.2174/9789815049633123010004
|
| 19 |
Yi Hua Low, Celestine Jia Ling Loh, Daniel Yang Yao Peh, Axel Jun Ming Chu, Shuting Han, Han Chong Toh. Pathogenesis and therapeutic implications of EBV-associated epithelial cancers. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1202117
|
| 20 |
Byung Woog Kang, YongHun Choi, Oh Kyoung Kwon, Seung Soo Lee, Ho Young Chung, Wansik Yu, Han Ik Bae, An Na Seo, Hyojeung Kang, Suk Kyeong Lee, Seong Woo Jeon, Keun Hur, Jong Gwang Kim. High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer. Oncotarget 2017; 8(9): 14988 doi: 10.18632/oncotarget.14744
|
| 21 |
Hector Hernandez-Vargas, Henri Gruffat, Marie Pierre Cros, Audrey Diederichs, Cécilia Sirand, Romina C. Vargas-Ayala, Antonin Jay, Geoffroy Durand, Florence Le Calvez-Kelm, Zdenko Herceg, Evelyne Manet, Christopher P. Wild, Massimo Tommasino, Rosita Accardi. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05713-2
|
| 22 |
William KK Wu, Jun Yu, Matthew TV Chan, Ka F To, Alfred SL Cheng. Combinatorial epigenetic deregulation by Helicobacter pylori
and Epstein-Barr virus infections in gastric tumourigenesis. The Journal of Pathology 2016; 239(3): 245 doi: 10.1002/path.4731
|
| 23 |
Hugo Manuel Lopes de Sousa, Joana Patrícia Costa Ribeiro, Mafalda Basílio Timóteo. Epstein-Barr Virus - New Trends. Infectious Diseases 2021; 11 doi: 10.5772/intechopen.93649
|
| 24 |
Yong Zhang, Zheng Peng, Yunshan Zhao, Lin Chen. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC. Medical Science Monitor 2016; 22: 1415 doi: 10.12659/MSM.896118
|
| 25 |
Yunchai Lin, Dan Hu, Qiang Zhou, Xiangdong Lin, Jinxiu Lin, Feng Peng. The fasting blood glucose and long non-coding RNA SNHG8 predict poor prognosis in patients with gastric carcinoma after radical gastrectomy. Aging 2018; 10(10): 2646 doi: 10.18632/aging.101576
|
| 26 |
Yongzhan Nie, Kaichun Wu, Jun Yu, Qiaoyi Liang, Xiqiang Cai, Yulong Shang, Jinfeng Zhou, Kaifeng Pan, Liping Sun, Jingyuan Fang, Yuan Yuan, Weicheng You, Daiming Fan. A global burden of gastric cancer: the major impact of China. Expert Review of Gastroenterology & Hepatology 2017; 11(7): 651 doi: 10.1080/17474124.2017.1312342
|
| 27 |
Yi-Fan Qi, Mengyang Liu, Yan Zhang, Wen Liu, Hua Xiao, Bing Luo. EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer. Virus Research 2019; 272: 197735 doi: 10.1016/j.virusres.2019.197735
|
| 28 |
Yuanyuan Jiang, Hua Xiao, Lingling Sun, Yan Zhang, Shuzhen Liu, Bing Luo. LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer. Virus Research 2021; 297: 198399 doi: 10.1016/j.virusres.2021.198399
|
| 29 |
Yun‐Yun Xu, Ting Li, Ao Shen, Xiao‐Qiong Bao, Jin‐Fei Lin, Li‐Zhen Guo, Qi Meng, Dan‐Yun Ruan, Qi‐Hua Zhang, Zhi‐Xiang Zuo, Zhao‐lei Zeng. FTO up‐regulation induced by MYC suppresses tumour progression in Epstein‒Barr virus‐associated gastric cancer. Clinical and Translational Medicine 2023; 13(12) doi: 10.1002/ctm2.1505
|
| 30 |
Masashi Fukayama, Akiko Kunita, Atsushi Kaneda. Human Herpesviruses. Advances in Experimental Medicine and Biology 2018; 1045: 437 doi: 10.1007/978-981-10-7230-7_20
|
| 31 |
Wen Liu, Hua Xiao, Hui Song, Shucai An, Bing Luo. Transcriptome sequencing of LMP2A-transfected gastric cancer cells identifies potential biomarkers in EBV-associated gastric cancer. Virus Genes 2022; 58(6): 515 doi: 10.1007/s11262-022-01925-5
|
| 32 |
Dong Won Baek, Byung Woog Kang, Soyoon Hwang, Jong Gwang Kim, An Na Seo, Han Ik Bae, Oh Kyoung Kwon, Seung Soo Lee, Ho Young Chung, Wansik Yu. Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer. Chonnam Medical Journal 2017; 53(2): 140 doi: 10.4068/cmj.2017.53.2.140
|
| 33 |
Jaffer A. Ajani, Jeeyun Lee, Takeshi Sano, Yelena Y. Janjigian, Daiming Fan, Shumei Song. Gastric adenocarcinoma. Nature Reviews Disease Primers 2017; 3(1) doi: 10.1038/nrdp.2017.36
|
| 34 |
Rambabu Kantipudi, Sugandha Kumar Pavuluri. Bioanalytical method development and validation for the simultaneous estimation of Olanzapine and Samidorphan in rabbit plasma by using HPLC–MS/MS and application to pharmacokinetic study. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-023-00570-5
|
| 35 |
Reza Ranjbar, Mojtaba Behjatfar, Ali Teimouri, Arad Aghaie Fard, Mahmood Maniati, Mortaza Taheri‐Anganeh. Long non‐coding RNAs and microorganism‐associated cancers. Cell Biochemistry and Function 2021; 39(7): 844 doi: 10.1002/cbf.3657
|
| 36 |
Chun‐Yi Tsai, Yu Yin Liu, Keng‐Hao Liu, Jun‐Te Hsu, Tse‐Ching Chen, Cheng‐Tang Chiu, Ta‐Sen Yeh. Comprehensive profiling of virus microRNAs of Epstein–Barr virus‐associated gastric carcinoma: highlighting the interactions of ebv‐Bart9 and host tumor cells. Journal of Gastroenterology and Hepatology 2017; 32(1): 82 doi: 10.1111/jgh.13432
|
| 37 |
Yunqing Zeng, Huimin Rong, Jianwei Xu, Ruyue Cao, Shuhua Li, Yanjing Gao, Baoquan Cheng, Tao Zhou. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.823905
|
| 38 |
Habibollah Mirzaei, Hossein Goudarzi, Gita Eslami, Ebrahim Faghihloo. Role of viruses in gastrointestinal cancer. Journal of Cellular Physiology 2018; 233(5): 4000 doi: 10.1002/jcp.26194
|
| 39 |
Wing Sum Shin, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To, Wei Kang. Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr Virus. Cancers 2023; 15(20): 4993 doi: 10.3390/cancers15204993
|
| 40 |
Jing-jing Jing, Ze-yang Wang, Hao Li, Li-ping Sun, Yuan Yuan. Key elements involved in Epstein–Barr virus-associated gastric cancer and their network regulation. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0637-5
|
| 41 |
Matthew J. Olnes, Holly A. Martinson. Recent advances in immune therapies for gastric cancer. Cancer Gene Therapy 2021; 28(9): 924 doi: 10.1038/s41417-021-00310-y
|
| 42 |
Ahmad Adebayo Irekeola, Engku Nur Syafirah E.A.R., Yusuf Wada, Rohimah Mohamud, Norhafiza Mat Lazim, Chan Yean Yean, Rafidah Hanim Shueb. Prevalence of EBV infection in 1157 diseased cohorts in Nigeria: A systematic review and meta-analysis. Indian Journal of Medical Microbiology 2022; 40(3): 420 doi: 10.1016/j.ijmmb.2022.03.008
|
| 43 |
Charu Sonkar, Nidhi Varshney, Siva Koganti, Hem Chandra Jha. Kinases and therapeutics in pathogen mediated gastric cancer. Molecular Biology Reports 2022; 49(3): 2519 doi: 10.1007/s11033-021-07063-9
|
| 44 |
Changyan Zou, Jinrong Liao, Dan Hu, Ying Su, Huamei Lin, Keyu Lin, Xingguan Luo, Xiongwei Zheng, Lurong Zhang, Tao Huang, Xiandong Lin. SNHG8 Promotes the Progression of Epstein–Barr Virus-Associated Gastric Cancer via Sponging miR-512-5p and Targeting TRIM28. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.734694
|
| 45 |
Amr M. El‐Araby, Abdelrahman A. Fouad, Amr M. Hanbal, Sara M. Abdelwahab, Omar M. Qassem, Moustafa E. El‐Araby. Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises. Archiv der Pharmazie 2016; 349(2): 73 doi: 10.1002/ardp.201500375
|
| 46 |
Shengwei Zhang, Yonggang Pei, Fengchao Lang, Kunfeng Sun, Rajnish Kumar Singh, Zachary L. Lamplugh, Abhik Saha, Erle S. Robertson, Benjamin E Gewurz. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation. PLOS Pathogens 2019; 15(1): e1007514 doi: 10.1371/journal.ppat.1007514
|
| 47 |
Jing Liu, Chunxia Yang, Yufang Gu, Chong Li, Huamei Zhang, Wenfang Zhang, Xueqing Wang, Nan Wu, Chunyan Zheng. Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma. Cellular & Molecular Biology Letters 2018; 23(1) doi: 10.1186/s11658-018-0070-8
|
| 48 |
Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee. Tumor immune response and immunotherapy in gastric cancer. Journal of Pathology and Translational Medicine 2020; 54(1): 20 doi: 10.4132/jptm.2019.10.08
|
| 49 |
Madiha Naseem, Afsaneh Barzi, Christine Brezden-Masley, Alberto Puccini, Martin D. Berger, Ryuma Tokunaga, Francesca Battaglin, Shivani Soni, Michelle McSkane, Wu Zhang, Heinz-Josef Lenz. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treatment Reviews 2018; 66: 15 doi: 10.1016/j.ctrv.2018.03.006
|
| 50 |
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023; : 3 doi: 10.1007/978-981-99-0815-8_1
|
| 51 |
Sadegh Fattahi, Mohadeseh Kosari‐Monfared, Elham Ghadami, Monireh Golpour, Parastoo Khodadadi, Mohammad Ghasemiyan, Haleh Akhavan‐Niaki. Infection‐associated epigenetic alterations in gastric cancer: New insight in cancer therapy. Journal of Cellular Physiology 2018; 233(12): 9261 doi: 10.1002/jcp.27030
|
| 52 |
Xin Yuan, Yuheng Yan, Miaomiao Xue. Small nucleolar RNA host gene 8: A rising star in the targets for cancer therapy. Biomedicine & Pharmacotherapy 2021; 139: 111622 doi: 10.1016/j.biopha.2021.111622
|
| 53 |
Shyam Singh, Hem Chandra Jha. Status of Epstein-Barr Virus Coinfection withHelicobacter pyloriin Gastric Cancer. Journal of Oncology 2017; 2017: 1 doi: 10.1155/2017/3456264
|